D75.84
BillableOther platelet-activating anti-PF4 disorders
Other platelet-activating anti-PF4 disorders
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Spontaneous heparin-induced thrombocytopenia syndrome (without heparin exposure)
- Thrombosis with thrombocytopenia syndrome
- Vaccine-induced thrombotic thrombocytopenia
Excludes 2
Conditions not included here, but the patient may have both
- •autoimmune disease (systemic) NOSM35.9
- •certain conditions originating in the perinatal periodP00-P96
- •complications of pregnancy, childbirth and the puerperiumO9A)O00
- •congenital malformations, deformations and chromosomal abnormalitiesQ00-Q99
- •endocrine, nutritional and metabolic diseasesE00-E88
- •human immunodeficiency virus [HIV] diseaseB20
- •injury, poisoning and certain other consequences of external causesS00-T88
- •neoplasmsC00-D49
- •symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedR00-R94
- •acute lymphadenitisL04
- •chronic lymphadenitisI88.1
- •enlarged lymph nodesR59
- •hypergammaglobulinemia NOSD89.2
- •lymphadenitis NOSI88.9
- •mesenteric lymphadenitis (acute) (chronic)I88.0
Use Additional Code
Additional codes that should follow this code
Related Codes(4)
Also Known As / Clinical Terms(29)
SNOMED CT
- Adverse reaction to COVID-19 vaccine1156256003
- Adverse reaction to component of vaccine product against severe acute respiratory syndrome coronavirus 21156256003
- COVID-19 vaccine adverse reaction1156256003
- Adverse reaction to COVID-19 non-replicating viral vector vaccine1157106007
- Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein1157106007
- COVID-19 non-replicating viral vector vaccine adverse reaction1157106007
- TTS (thrombosis with thrombocytopenia syndrome) following non-replicating adenovirus vector COVID-19 vaccination1340018008
- Thrombosis with thrombocytopenia syndrome following vaccination with non-replicating adenovirus vector vaccine for severe acute respiratory syndrome coronavirus 21340018008
- Post vaccination thrombosis with thrombocytopenia1354754001
- Thrombosis with thrombocytopenia syndrome following vaccination1354754001
UMLS
Clinical Terms
- Adverse reaction to COVID-19 non-replicating viral vector vaccine
- Spontaneous heparin-induced thrombocytopenia syndrome (without heparin exposure)
- Adverse reaction to COVID-19 vaccine
- TTS (thrombosis with thrombocytopenia syndrome) following non-replicating adenovirus vector COVID-19 vaccination
- Thrombosis with thrombocytopenia syndrome following vaccination
- Thrombosis with thrombocytopenia syndrome following vaccination with non-replicating adenovirus vector vaccine for severe acute respiratory syndrome coronavirus 2
- Thrombosis with thrombocytopenia syndrome
- Vaccine-induced thrombotic thrombocytopenia
- Post vaccination thrombosis with thrombocytopenia
- TTS
- Adverse reaction to component of vaccine product against severe acute respiratory syndrome coronavirus 2
- Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
- COVID-19 vaccine adverse reaction
- COVID-19 non-replicating viral vector vaccine adverse reaction
Frequently Asked Questions
What is the ICD-10 code for other platelet-activating anti-pf4 disorders?
The ICD-10-CM code for other platelet-activating anti-pf4 disorders is D75.84. The full clinical description is "Other platelet-activating anti-PF4 disorders". D75.84 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code D75.84 mean?
ICD-10-CM code D75.84 represents “Other platelet-activating anti-PF4 disorders”. It is classified under Chapter 3: Diseases of the Blood and Blood-Forming Organs and is a billable/specific code that can be used on a claim.
Is D75.84 a billable code?
Yes, D75.84 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is D75.84 in?
D75.84 is in Chapter 3: Diseases of the Blood and Blood-Forming Organs (codes D50-D89).
Are additional codes required with D75.84?
Yes, when using D75.84, also report: code, if applicable, for adverse effect of other viral vaccine (T50.B95-).
What SNOMED CT codes does D75.84 map to?
D75.84 maps to 4 SNOMED CT concepts: 1157106007, 1156256003, 1354754001, 1340018008. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for D75.84?
D75.84 is linked to 4 UMLS Concept Unique Identifiers: C5674889, C5676322, C5554239, C5676323. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does D75.84 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like other platelet-activating anti-pf4 disorders affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of D75.84?
There is no direct ICD-11 mapping available for D75.84 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.